GSK Carving Out Strategic Strengths In Emerging Markets: Euro-Biotech Partnering Summit
This article was originally published in PharmAsia News
Executive Summary
GSK VP Paul Bolno on market-specific opportunities in Asia.
You may also be interested in...
Is China A Black Swan For Big Pharma? (Part 2 of 2)
[Editor's note: This is part two of a two part story; part one appeared in PharmAsia News, April 25, 2010.]
Beijing Firm Launches Clinical Trial On Stem Cell Treatment For Diabetes
BEIJING - The chief executive officer of the Beijing-headquartered firm Cellonis says that preliminary results from an ongoing clinical trial in the Chinese capital are a promising sign of the potential for widening use of a stem cell-based treatment for diabetes in the future
Southeast Asian Regulators Ramp Up Anti-Corruption, Bribery Enforcement Ahead of ASEAN Pact
Regulators in Southeast Asia are working to tighten bribery and corruption enforcement as part of a broader push ahead of an Association of Southeast Asian Nations trade pact in 2015 for greater transparency in pharmaceuticals.